Poloxamer 188 Attenuates Ischemia-Reperfusion-Induced Lung Injury by Maintaining Cell Membrane Integrity and Inhibiting Multiple Signaling Pathways.

Saved in:
Bibliographic Details
Title: Poloxamer 188 Attenuates Ischemia-Reperfusion-Induced Lung Injury by Maintaining Cell Membrane Integrity and Inhibiting Multiple Signaling Pathways.
Authors: Tang SE; Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei, Taiwan.; Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan., Liao WI; Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan., Pao HP; The Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan., Hsu CW; Department of Emergency and Critical Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan., Wu SY; Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei, Taiwan., Huang KL; Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei, Taiwan.; Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan., Chu SJ; Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Source: Frontiers in pharmacology [Front Pharmacol] 2021 Jul 15; Vol. 12, pp. 650573. Date of Electronic Publication: 2021 Jul 15 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1663-9812
DOI:10.3389/fphar.2021.650573